Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Lundbeck And Axsome Rival Candidate Data Raise Prospects For First Alzheimer’s Agitation Approvals
Filings On The Horizon?
Dec 02 2022
•
By
Ayisha Sharma
Around 45% Of Alzheimer's Patients Experience Agitation • Source: Shutterstock
More from Clinical Trials
More from R&D